Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) SUSRF Stock

$5.20   3.999996%
Add to favorites
Market Cap
$364.15M
LOW - HIGH [24H]
$5.20 - $5.20
VOLUME [24H]
$200.00
P/E Ratio
27.36
Earnings per share
$0.19
ISIN
SE0014428512
Price   Prediction

Surgical Science Sweden AB (publ) Price Chart

Sorry, that's all we've gotfor now...

Surgical Science Sweden AB (publ) SUSRF Financial and Trading Overview

Surgical Science Sweden AB (publ) stock price 5.2 USD
Previous Close 5 USD
Open 5.2 USD
Bid 5.03 USD x 120000
Ask 5.27 USD x 20000
Day's Range 5.2 - 5.2 USD
52 Week Range 2.84 - 10.45 USD
Volume 200 USD
Avg. Volume 16 USD
Market Cap 350.15M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) 26.31579
EPS (TTM) 0.19 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

SUSRF Valuation Measures

Enterprise Value N/A
Trailing P/E 26.31579
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.0593338
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Surgical Science Sweden AB (publ) Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -52.15%
S&P500 52-Week Change 18.35%
52 Week High 10.45 USD
52 Week Low 2.84 USD
50-Day Moving Average 4.06 USD
200-Day Moving Average 3.63 USD

SUSRF Share Statistics

Avg. Volume (3 month) 16 USD
Avg. Daily Volume (10-Days) 100 USD
Shares Outstanding 51.03M
Float 36.94M
Short Ratio N/A
% Held by Insiders 26.50%
% Held by Institutions 44.10%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 5:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 9.10%
Operating Margin (ttm) 0%
Gross Margin 66.49%
EBITDA Margin 13.59%

Management Effectiveness

Return on Assets (ttm) 1.43%
Return on Equity (ttm) 2.10%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 21.69%
Gross Profit (ttm) N/A
EBITDA 138.99M USD
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) 0.19
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 0.06 USD
Current Ratio (mrq) 4.242
Book Value Per Share (mrq) 84.269

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) -39107000 USD

Profile of Surgical Science Sweden AB (publ)

Country United States
State N/A
City Gothenburg
Address Drakegatan 7A
ZIP 412 50
Phone 46 3 17 41 65 60
Website https://www.surgicalscience.com
Industry Health Information Services
Sector(s) Healthcare
Full Time Employees 313

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.

Q&A For Surgical Science Sweden AB (publ) Stock

What is a current SUSRF stock price?

Surgical Science Sweden AB (publ) SUSRF stock price today per share is 5.2 USD.

How to purchase Surgical Science Sweden AB (publ) stock?

You can buy SUSRF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Surgical Science Sweden AB (publ)?

The stock symbol or ticker of Surgical Science Sweden AB (publ) is SUSRF.

Which industry does the Surgical Science Sweden AB (publ) company belong to?

The Surgical Science Sweden AB (publ) industry is Health Information Services.

How many shares does Surgical Science Sweden AB (publ) have in circulation?

The max supply of Surgical Science Sweden AB (publ) shares is 70.03M.

What is Surgical Science Sweden AB (publ) Price to Earnings Ratio (PE Ratio)?

Surgical Science Sweden AB (publ) PE Ratio is 27.36842000 now.

What was Surgical Science Sweden AB (publ) earnings per share over the trailing 12 months (TTM)?

Surgical Science Sweden AB (publ) EPS is 0.19 USD over the trailing 12 months.

Which sector does the Surgical Science Sweden AB (publ) company belong to?

The Surgical Science Sweden AB (publ) sector is Healthcare.

$2.67T
Total marketcap
$88.26B
Total volume
BTC 59.25%     ETH 11.11%
Dominance
Select currency